Therefore, since PARP-14 is involved in a transduction pathway mediated by JNKs, promoting survival in multiple myeloma (16), we hypothesized the activation of this signaling pathway also in our αTC1.6 cell line, in an inflammatory experimental model. Here, PARP14 is linked to plasma cell myeloma.